Abstract
The current manuscript describes two molecules that were designed against PPARγ and GPR40 receptors. The preparation of the compounds was carried out following a synthetic route of multiple steps. Then, the mRNA expression levels of PPARγ, GLUT4, and GPR40 induced by compounds were measured and quantified in adipocyte and β-pancreatic cell cultures. The synthesized compound 1 caused an increase in the 4-fold expression of mRNA of PPARγ regarding the control and had a similar behavior to the pioglitazone, while compound 2 only increased 2-fold the expression. Also, the compound 1 increased to 7-fold the GLUT4 expression levels, respect to the control and twice against the pioglitazone. On the other hand, the 1 increase 3-fold GPR40 expression, and compound 2 had a minor activity. Besides, 1 and 2 showed a moderated increase on insulin secretion and calcium mobilization versus the glibenclamide. Based on the molecular docking studies, the first compound had a similar conformation to co-crystal ligands into the binding site of both receptors. The poses were docked keeping the most important interactions and maintaining the interaction along the Molecular Dynamics simulation (20 ns). Finally, compound (1) showed an antihyperglycemi...Continue Reading
References
Feb 1, 1996·Journal of Molecular Graphics·W HumphreyK Schulten
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
May 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·William L Jorgensen, Julian Tirado-Rives
Oct 14, 2005·Journal of Computational Chemistry·James C PhillipsKlaus Schulten
Aug 19, 2007·The Journal of Biological Chemistry·Chi Shing SumMarvin C Gershengorn
May 24, 2008·European Journal of Pharmacology·Rebeca Garcia-MacedoMiguel Cruz
Jun 8, 2011·Structure·Maxim V Shapovalov, Roland L Dunbrack
Jun 22, 2011·Journal of Computer-aided Molecular Design·Laura GuaschSantiago Garcia-Vallvé
Jul 24, 2012·Journal of Ethnopharmacology·Rolffy Ortiz-AndradeAlejandro García-Carrancá
Apr 9, 2013·PloS One·Bong Sook JhunYisang Yoon
Jun 6, 2014·ACS Medicinal Chemistry Letters·Jiwen Jim LiuJonathan B Houze
Jul 15, 2015·Archives of Medical Science : AMS·Georgios S PapaetisThemistoklis N Panagiotou
Jul 29, 2015·Proceedings of the National Academy of Sciences of the United States of America·Bingbing WuWeiping Han
Nov 26, 2015·Journal of Advanced Pharmaceutical Technology & Research·Mabel ParimalaFrancis Gricilda Shoba
Dec 1, 2015·Bioorganic & Medicinal Chemistry·Quanqing GaoDavid E Hibbs
May 25, 2016·Scientific Reports·João V RibeiroKlaus Schulten
Oct 7, 2016·Scientific Reports·Davide CapelliAntonio Lavecchia
Feb 23, 2017·The Journal of Physical Chemistry. B·Leela S DoddaWilliam L Jorgensen
Mar 3, 2017·Pharmacognosy Research·Fernando CalzadaJosé Correa-Basurto
Mar 28, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sergio Hidalgo-FigueroaJulio C Almanza-Pérez
Apr 27, 2017·Nucleic Acids Research·Leela S DoddaWilliam L Jorgensen
Oct 27, 2017·Chemical Biology & Drug Design·Daniel Alencar RodriguesCarlos Alberto Manssour Fraga
Feb 9, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Blanca Colín-LozanoGabriel Navarrete-Vazquez
Apr 5, 2018·Bioorganic & Medicinal Chemistry Letters·Khaled M DarwishMohamed A Helal
Oct 30, 2019·Pharmaceuticals·Raquel VieiraEliana B Souto